Jon Mogford
Jon Mogford, PhD, who has an extensive background in biology research and its applications in the field of defense medicine and therapeutics. His expertise includes wound healing/regeneration, cellular therapies, tissue engineering and vascular physiology. His specific interests focus on therapeutics for wounded soldiers, protein design processes and drug delivery. He has authored or co-authored 29 peer-reviewed publications. He served as senior vice president and chief operating office of Texas A&M Health from 2021-2023. He held several roles at the Defense Advanced Research Projects Agency (DARPA) from 2005 to 2011. He co-founded Safi Biotherapuetics in 2019, a company focused on cell therapy, and he served as CEO for SmartPharm Therpuetics, a startup specialzing in RNA therapies.
Latest News
- IHMC’s new humanoid Alex aces its first off-sit, off-tether demonstration
- A Letter From Our CEO
- IHMC project helps pioneer new tools for warfighters
- STEM-Talk: Doug Cooke talks about strengths and flaws of NASA’s Artemis mission
- IHMC hosts national workshop on collaborative autonomy
- Community turnout lifts IHMC clinical trial to a great start
- Two IHMC researchers named to top posts in worldwide organizations
- Public learns about robots, drones, virtual reality, Healthspan advances and more at open house
- STEM-Talk: Tommy Wood shares science-backed strategies to enhance your mental sharpness